Chiropractic Offers Long Term Benefits for Fibromyalgia Sufferers

If you suffer with fibromyalgia, you are not alone, as Dr. Covington sees many patients with this particular issue in our Yakima chiropractic clinic. As a matter of fact, the Centers for Disease Control and Prevention (CDC) reports that roughly two percent of all adults in the United States have fibromyalgia pain. Thankfully, chiropractic therapy is one treatment option that can provide positive results.

Research Shows Chiropractic Therapy Lessens Fibromyalgia Pain

In a medical study published in mid-2015, 215 adults with fibromyalgia were assessed based on factors ranging from pain to quality of sleep to the levels of depression symptoms and anxiety they felt. Then they were split into two groups with one group receiving a multi-modal therapy plan for three months and the second group receiving the same program with the addition of chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The subjects who received chiropractic treatment in addition to the multi-disciplinary treatment approach reported greater results in all areas (pain, sleep, depression, and anxiety) at three months post-treatment when compared to the study participants who received multi-modal therapy without chiropractic therapy. Additionally, those positive results were lasting as the patients reported continued improvement one full year later.

Fibromyalgia issues can significantly diminish your quality of life, both mentally and physically. If you're dealing with fibromyalgia, we might be able to help.

You don't have to suffer! To learn what Dr. Covington can do for your fibromyalgia pain, call our Yakima chiropractic office today.

Research

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.